Federal contractor · public award history
XLCARE PHARMACEUTICALS INC
Parent: XLCARE PHARMACEUTICALS INC MEAUS5WHBJJ7
- Awards we know about
- 14
- Typical size
- —
- Middle of their public awards
- Dollars on those awards
- $0
SAM.gov registration
Public extract 2026-07-05
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Jun 3, 2027
- Activation date
- Jun 3, 2026
- Primary NAICS (SAM)
- 325412
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Veterans Affairs (14)
Industries & product codes
Award history
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- Department of Veterans Affairs—
NEW AWARD FOR GABAPENTIN CAPSULES WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS NOVEMBER 11, 2023 THROUGH NOVEMBER 10, 2024 WITH FOUR ONE YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR OXCARBAZEPINE WITH XLCARE PHARMACEUTICALS. PERIOD OF PERFORMANCE IS OCT 14, 2024 TO OCT 13, 2025 WITH FOUR ONE-YEAR OPTIONS
- Department of Veterans Affairs—
NEW AWARD FOR LOSARTAN TABLETS WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 9/24/2025-9/23/2026.
- Department of Veterans Affairs—
NEW AWARD FOR TOPIRAMATE TABLETS WITH XLCARE. ORDERING PERIOD IS OCT 31, 2025 TO OCT 30, 2026 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR PANTOPRAZOLE TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD IS JUNE 26, 2022 TO JUNE 25, 2023 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR LEVETIRACETAM TABLETS WITH XLCARE PHARMACEUTICALS. PERIOD OF PERFORMANCE IS MAY 24, 2021 TO MAY 23, 2022 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR LACOSAMIDE INJECTIONS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD IS MAY 13, 2023 TO MAY 12, 2024 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR MONTELUKAST NA TABLETS WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE MAY 10, 2021 THROUGH MAY 9, 2022 WITH FOUR ONE YEAR OPTIONS.
- Department of Veterans Affairs—
AWARD TO XLCARE PHARMACEUTICALS FOR METHOCARBAMOL TABLETS FOR THE BASE YEAR WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
2 LINE ITEMS DUTASTERIDE CAPSULES. AWARDED FOR A BASE YEAR OF 12/23/2021 TO 12/22/2022 PLUS 4 ONE-YEAR OPTION PERIODS.
- Department of Veterans Affairs—
NEW AWARD FOR LEVOTHYROXINE NA TABLETS WITH XLCARE PHARMACEUTICALS, INC. BASE YEAR ORDERING PERIOD IS JAN 27, 2025 THROUGH JAN 26, 2026 WITH FOUR ONE-YEAR OPTIONS
- Department of Veterans Affairs—
12 LINE ITEMS FOR ARIPIPRAZOLE TABLETS. AWARDED FOR A BASE YEAR AND 4 ONE-YEAR OPTION PERIODS.
- Department of Veterans Affairs—
ELIGIBLE PARTICIPANTS ARE VA, IHS, BOP, FHCC AND ORDERING FACILITIES UNDER THE DOD PRIME VENDOR PROGRAM.
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.